G Hale1, J M Phillips. Show Affiliations » 1. Department of Pathology, University of Cambridge, U.K.
Abstract
Entities: Chemical
Mesh： See more » AlemtuzumabAnimalsAntibodies, Anti-Idiotypic/biosynthesisAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntibodies, Neoplasm/adverse effectsAntibodies, Neoplasm/therapeutic useAntilymphocyte Serum/therapeutic useBiomarkersClinical Trials as TopicHumansImmunoglobulin G/therapeutic useMiceMultiple Sclerosis/therapyRatsVasculitis/therapy
Substances： See more » Antibodies, Anti-IdiotypicAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, NeoplasmAntilymphocyte SerumBiomarkersImmunoglobulin GAlemtuzumab
Year: 1995 PMID： 8654681 DOI： 10.1042/bst0231057
Source DB: PubMed Journal: Biochem Soc Trans ISSN： 0300-5127 Impact factor: 5.407